Mail on Sunday pays ‘substantial’ damages over ‘statin deniers’ articles
A statement by Matt Hancock on statins was found to have been used in a "misleading" way.
By
Fighting for quality news media in the digital age.
Press Gazette’s coverage of all media publishers: print, online, broadcast and B2B. This is the place to find must-read content about the future of the media industry
A statement by Matt Hancock on statins was found to have been used in a "misleading" way.
ByKing had been off air for several months before the announcement.
ByScott Trust approves sale of Observer as journalists strike in protest at deal.
ByMedia Concierge still has to make its offer formally.
ByThe BBC’s data feed was licensed from investment research firm Morningstar.
BySports media co-founder wonders how the next businesses like his will cope.
ByPerplexity chief business officer tells Press Gazette publishers have "nothing to lose" if they sign up to the programme.
ByFuture share price bounces back on 2024 results which show modest return to growth.
By